HMCC attracts investor Holland Capital for further growth
Amsterdam, 2 November 203 – Investment firm Holland Capital is investing in HMCC Medical Group (HMCC), a provider that offers remote support for primary care. The investment is led by Holland Capital, in partnership with Weijenberg Invest. With this investment, HMCC can further develop its services and technologies.
Remote Healthcare
The Dutch healthcare system is facing challenges due to an aging population and a shortage of healthcare professionals. This highlights the need for solutions like HMCC that optimize resources while improving the quality of care. HMCC is committed to improve the accessibility of general practitioner practices and clinics. By deploying a professional medical team, HMCC relieves the pressure on practices and medical staff, allowing them to focus on patient care. HMCC’s team consists of experienced medical assistants, triage personnel, and nurses who provide remote expert advice to patients. They carefully assess the urgency of medical inquiries and facilitate effective communication. The on-site assistant in the general practitioner’s office can then fully concentrate on providing physical care to patients.
Innovative Growth
With the investment, HMCC can further develop and expand its services and technologies to better meet the growing demand for remote healthcare.
“The approach of HMCC contributes to improving the accessibility of the general practitioner’s office for patients and reducing the workload at the practice. We are excited to invest in a company that plays a central role in efficiently facilitating remote healthcare,” says Jan-Frens van Giessel, partner at Holland Capital. Following the investment in the healthcare platform HealthConnected in 2020, this is Holland Capital’s second investment focused on efficiency and digitalization in primary care.
Patrick Eliasar, CEO of HMCC, says, “Thanks to the investment from Holland Capital, we can expand our services and further develop the technology to meet the growing needs of remote healthcare. The investment also allows us to move forward with a much clearer vision of the future of healthcare, where the role of remote patient care becomes not only essential for general practitioners, hospitals, and clinics but also for pharmacies, for example.”
About HMCC
HMCC is a leading medical contact center specializing in improving the accessibility of general practitioner practices. With a team of experienced professionals, HMCC provides solutions that contribute to quality healthcare and remote care. Dozens of general practitioner practices and clinics already use HMCC’s services.
About Holland Capital
For the past 40 years, Holland Capital has responsibly and successfully invested in over 180 promising companies. With a clear investment strategy, the firm is active in attractive growth markets, including Healthcare, Technology, and Agrifood. The experienced and engaged investment team understands what entrepreneurship entails. They aim for an open, sustainable, and professional relationship with the management teams of the companies they invest in, with the common goal of achieving growth. Holland Capital is supported by a broad network of successful entrepreneurs and has offices in Amsterdam and Düsseldorf.
Yenlo and 42Crunch Enter Strategic Partnership to Secure APIs and Enforce API Policies
Yenlo and 42Crunch Enter Strategic Partnership to Secure APIs and Enforce API Policies Yenlo will extend the value it brings to API customers worldwide by adding 42Crunch API security services to its existing service portfolio, including Connext, Yenlo’s WSO2-based...
Volgende stap in groeiambities: Valori benoemt Jaap Merkus als CEO
Volgende stap in groeiambities: Valori benoemt Jaap Merkus als CEO Utrecht, 11 november 2019 – Software Testing en Quality Assurance specialist Valori maakt bekend dat Jaap Merkus per 1 december wordt benoemd als Chief Executive Officer (CEO). Met de komst van Merkus...
Next step in growth ambitions: Valori appoints Jaap Merkus as CEO
Next step in growth ambitions: Valori appoints Jaap Merkus as CEO Utrecht, 11th of November 2019 – Software Testing and Quality Assurance Specialist Valori announces that Jaap Merkus will be appointed Chief Executive Officer (CEO) effective December 1, 2019. With the...
Yenlo Completes Advisory Board with the Addition of Sjoerd Blüm as a Third Strategic Member
Yenlo Completes Advisory Board with the Addition of Sjoerd Blüm as a Third Strategic Member Advisory board will enable global system integrator and API management specialist Yenlo to leverage the business insights of leading industry and financial executives in...
Sjoerd Blüm aangesteld als lid Raad van Commissarissen Yenlo
Sjoerd Blüm aangesteld als lid Raad van Commissarissen Yenlo Amsterdam, 26 september 2019 – Integratie- en API-Managementspecialist Yenlo kondigt vandaag aan dat Sjoerd Blüm, CIO bij Royal Schiphol Group, is aangesteld als lid van de Raad van Commissarissen (RvC). Met...
Defibrion haalt investeerder binnen voor uitrol buy-and-build strategie
Defibrion haalt investeerder binnen voor uitrol buy-and-build strategie Amsterdam, 24 september 2019 - Participatiemaatschappij Holland Capital investeert in Defibrion, een snelgroeiende leverancier van AED’s en andere producten en diensten op het vlak van...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl